Successful CMOs achieve growth by leveraging technology. Join us for GrowthBeat Summit on June 1-2 in Boston
, where we'll discuss how to merge creativity with technology to drive growth. Space is limited. Request your personal invitation here
While it’s remarkable that we can actually sequence entire genomes today, the process remains relatively expensive.
Genapsys aims to change that with its Genius system-on-a-chip sequencing technology (above), which is significantly cheaper than the competition and offers dramatically faster turnaround times. The company revealed today it has raised $8.5 million of a $13.5 million round, according to an SEC filing.
Genapsys’ $3,000 device takes the place of equipment that can cost more than $500,000, according to Bizjournals.
The Redwood City, California-based company was founded by Dr. Hesaam Esfandyarpour in 2006 and comes out of Stanford’s StartX program. In September, the company also received a $4 million grant from the National Human Genome Research Institute as part of funds meant to improve gene sequencing technology.
VentureBeat’s VB Insight team is studying marketing analytics...
Chime in here, and we’ll share the results